Inceptus Announces Completion Of Series A Financing For Inari Medical
Versant Ventures and U.S. Venture Partners back medical device start-up
ALISO VIEJO, Calif., Oct. 16, 2013
ALISO VIEJO, Calif., Oct. 16, 2013 /PRNewswire/ -- Inceptus Medical, LLC, a medical device company incubator, announced today that it has completed a $4.7M Series A financing for its first new company, Inari Medical Inc. The financing will provide the resources to develop and commercialize innovative devices for the interventional treatment of cardiovascular disease.
Versant Ventures and U.S. Venture Partners (USVP) led the funding round. "My colleagues at Versant and I are excited to be working with Inceptus to develop new medical device companies," said Kirk Nielsen, Managing Director at Versant Ventures. Kirk Nielsen and Don Milder at Versant Ventures and Jonathan Root, M.D. at USVP will serve as board members.
"We are pleased to continue to work with Versant Ventures and USVP who have supported us to build two previous successful companies, MicroVention (acquired by Terumo) and Sequent Medical Inc." said Bob Rosenbluth, Inceptus President & CEO. Inari Medical management, Bob Rosenbluth, Brian Cox and Paul Lubock will lead the company's initial development, clinical evaluation and product launch.
About Inceptus Medical
Inceptus was founded in 2011 as a medical device company incubator with a mission to create and foster innovative concepts into companies by providing a combination of experienced engineering, clinical research expertise, seasoned leadership and strong financial resources. The Inceptus team includes talented medical device engineers, serial entrepreneurs, executive managers and investors with a successful track record in the formation of medical device companies. Inceptus works closely with outside clinicians and inventors with promising ideas.
For more information, visit the company's website at inceptusmedical.com
About Versant Ventures
Versant Ventures is a leading venture capital firm that specializes in investments in game changing medical devices, biopharmaceuticals, and other life science opportunities. Founded in 1999, the firm consists of an experienced team of managing directors committed to helping entrepreneurs build successful companies that impact healthcare and improve quality of life. Versant's focus is medical devices, biopharmaceuticals, and other life sciences opportunities. Versant has $1.6 billion under management with over 75 companies in their portfolio. For more information visit versantventures.com.
About U.S. Venture Partners
USVP is a leading venture capital partnership, helping entrepreneurs transform their ideas and efforts into world-changing companies. USVP focuses on early-stage ventures in information technology and health care, where innovation is unbridled and has led to the creation of economic wealth and millions of jobs over the past thirty-plus years of the firm's existence. Areas of particular interest include data center and network technology, consumer and business services, digital media, communications, semiconductors, biopharmaceuticals and medical devices. The USVP team consists of former entrepreneurs, technologists, corporate executives, financial professionals and industry domain experts. For more information visit usvp.com.